학술논문
분화갑상선암 수술 후 갑상선자극호르몬 억제요법과 골다공증
이용수 107
- 영문명
- TSH Suppression after Differentiated Thyroid Cancer Surgery and Osteoporosis
- 발행기관
- 대한내분비외과학회
- 저자명
- 박경식(KyoungSik Park)
- 간행물 정보
- 『The Koreran journal of Endocrine Surgery』16권1호, 1~5쪽, 전체 5쪽
- 주제분류
- 의약학 > 일반외과학
- 파일형태
- 발행일자
- 2016.03.31
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
Thyroid stimulating hormone (TSH) suppression therapy has been known to play animportant role in lowering the risk of recurrence after surgery for differentiated thyroidcarcinoma. Osteoporosis is a major complication of TSH suppression. The purpose of thisstudy is to review the current thyroid stimulating hormone suppression therapy andosteoporosis risk and examine the proper TSH suppression after surgery for patients withdifferentiated thyroid cancer. Previous studies and current guidelines on TSH suppressionand osteoporosis were collected from databases in Korea and other countries and reviewed.According to the recommendations of the Korean Thyroid Association in 2010, initial TSHsuppression to below 0.1 mU/L is recommended for high-risk and intermediate-risk thyroidcancer patients, while TSH level at or slightly below the lower limit of normal (0.1∼0.5mU/L) is appropriate for low-risk patients. During follow-up, in patients with persistentdisease, the serum TSH should be maintained below 0.1 mU/L indefinitely in the absenceof specific contraindications, while in patients free of disease, especially those at low riskfor recurrence, the serum TSH may be kept within the low normal range (0.3∼2 mU/L). In2015, the American Thyroid Association recommended revised guidelines considering theinitial ATA risk classification, Tg level, Tg trend over time, and risk of TSH suppressionduring the long term follow-up period. Appropriate recommendations considering the riskstratification of thyroid cancer and adverse effects of TSH suppression are required toimprove the survival of differentiated thyroid cancer patients and minimize the adverseeffects of long-term therapy.
목차
Abstract
서 론
갑상선암 치료 권고안상의 위험도 분류 및 갑상선자극호르몬(TSH) 억제요법
갑상선자극호르몬(TSH) 억제요법이 골다공증에 미치는 영향
골다공증 위험도에 따른 TSH 억제요법 결정
결 론
REFERENCES
해당간행물 수록 논문
- 분화갑상선암 수술 후 갑상선자극호르몬 억제요법과 골다공증
- Non-recurrent Laryngeal Nerve Identified During Robotic Thyroidectomy in a Patient with Papillary Thyroid Carcinoma
- Papillary Thyroid Carcinoma with Retropharyngeal Node Metastasis Demonstrating Negative I-131 but Positive FDG Uptake on PET/CT
- Lateral Lymph Node Metastasis Prediction in Papillary Thyroid Cancer Patients with Suspicious Preoperative Imaging Findings
참고문헌
관련논문
의약학 > 일반외과학분야 BEST
- 간호대학생의 SNS 중독경향성, 간호정보역량, 정보윤리 의식이 환자 개인정보 보호 인식에 미치는 영향
- 아동․청소년대상 현실치료 집단상담 프로그램의 효과에 대한 메타분석
- 현실치료를 적용한 집단상담 프로그램이 청소년의 인터넷 중독에 미치는 영향
의약학 > 일반외과학분야 NEW
- Determinants of unhealthy living by gender, age group, and chronic health conditions across districts in Korea using the 2010-2017 Community Health Surveys
- Folate, vitamin B12, and homocysteine status in the Korean population: data from the 2013-2015 Korea National Health and Nutrition Examination Survey
- Incidence and case fatality of stroke in Korea, 2011-2020
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!